Drw Securities, LLC Incyte Corp Transaction History

Drw Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$51.18 - $63.75 $224,782 - $279,990	4,392 New	4,392 $266,000
Q1 2020 May 13, 2020	SELL	$63.18 - $85.97 $358,609 - $487,965	-5,676 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$73.04 - $95.72 $414,575 - $543,306	5,676 New	5,676 $496,000
Q1 2018 May 14, 2018	SELL	$83.06 - $100.98 $203,330 - $247,199	-2,448 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $229,034 - $285,436	2,448	2,448 $232,000

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Drw Securities, LLC with notifications on news.